Literature DB >> 12665583

Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression.

Behnom Farboud1, Herborg Hauksdottir, Yun Wu, Martin L Privalsky.   

Abstract

Retinoic acid receptors (RARs) are ligand-regulated transcription factors that play multiple roles in vertebrate development and differentiation. RARs as a class are capable of both repressing and activating target gene expression. Transcriptional repression is mediated through the recruitment of corepressor proteins such as SMRT. Notably, vertebrates encode three major forms of RARs, alpha, beta, and gamma, and these distinct RAR isotypes differ in the ability to recruit a corepressor. RAR alpha strongly interacts with SMRT and can repress target gene transcription, whereas RAR beta and -gamma interact with SMRT only weakly and fail to repress. We report here the use of a genetic suppressor approach, based on a yeast two-hybrid interaction assay using Saccharomyces cerevisiae, for the isolation of RAR beta mutants that have gained the RAR alpha-like corepressor phenotype, i.e., a strong interaction with SMRT and the ability to repress gene expression in vertebrate cells. Analysis of these gain-of-function mutants indicates that the different corepressor interaction properties of RAR alpha, -beta and -gamma are determined by a gating mechanism through which amino acid differences in the helix 3 region of these receptors influence the position of the receptor C-terminal helix 12 domain. As a consequence, the RAR beta and RAR gamma receptors appear to adopt a constitutively closed helix 12 conformation in the absence of hormone that may approximate the conformation of RAR alpha when bound to hormone agonist. This closed helix 12 conformation in RAR beta and RAR gamma blocks corepressor binding, prevents repression, and permits significant levels of target gene activation even in the absence of hormone. We refer to this phenomenon as a "gate-latch" model of corepressor regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665583      PMCID: PMC152560          DOI: 10.1128/MCB.23.8.2844-2858.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  84 in total

Review 1.  Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs.

Authors:  C A Hassig; S L Schreiber
Journal:  Curr Opin Chem Biol       Date:  1997-10       Impact factor: 8.822

Review 2.  Co-activators and co-repressors in the integration of transcriptional responses.

Authors:  J Torchia; C Glass; M G Rosenfeld
Journal:  Curr Opin Cell Biol       Date:  1998-06       Impact factor: 8.382

3.  Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

Authors:  L Z He; F Guidez; C Tribioli; D Peruzzi; M Ruthardt; A Zelent; P P Pandolfi
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.

Authors:  F Grignani; S De Matteis; C Nervi; L Tomassoni; V Gelmetti; M Cioce; M Fanelli; M Ruthardt; F F Ferrara; I Zamir; C Seiser; F Grignani; M A Lazar; S Minucci; P G Pelicci
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.

Authors:  B L Wagner; J D Norris; T A Knotts; N L Weigel; D P McDonnell
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Role of the histone deacetylase complex in acute promyelocytic leukaemia.

Authors:  R J Lin; L Nagy; S Inoue; W Shao; W H Miller; R M Evans
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

7.  A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.

Authors:  X Zhang; M Jeyakumar; S Petukhov; M K Bagchi
Journal:  Mol Endocrinol       Date:  1998-04

8.  Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.

Authors:  F Guidez; S Ivins; J Zhu; M Söderström; S Waxman; A Zelent
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

9.  The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70.

Authors:  G E Muscat; L J Burke; M Downes
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

10.  Requirement of corepressor binding of thyroid hormone receptor mutants for dominant negative inhibition.

Authors:  T Nagaya; M Fujieda; H Seo
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

View more
  22 in total

1.  Zebrafish retinoic acid receptors function as context-dependent transcriptional activators.

Authors:  Joshua S Waxman; Deborah Yelon
Journal:  Dev Biol       Date:  2011-01-27       Impact factor: 3.582

2.  SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways.

Authors:  Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2004-10-18       Impact factor: 5.157

3.  Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors.

Authors:  Michael L Goodson; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

4.  The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors.

Authors:  Martin L Privalsky; Sangho Lee; Johnnie B Hahm; Briana M Young; Rebecca N G Fong; Ivan H Chan
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

5.  Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity.

Authors:  Meghan D Rosen; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2009-04-30

6.  The ability of thyroid hormone receptors to sense t4 as an agonist depends on receptor isoform and on cellular cofactors.

Authors:  Amy Schroeder; Robyn Jimenez; Briana Young; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2014-03-27

Review 7.  The negative side of retinoic acid receptors.

Authors:  Elwood Linney; Susan Donerly; Laura Mackey; Betsy Dobbs-McAuliffe
Journal:  Neurotoxicol Teratol       Date:  2011-07-13       Impact factor: 3.763

Review 8.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

Review 9.  Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Authors:  Iván P Uray; Ethan Dmitrovsky; Powel H Brown
Journal:  Semin Oncol       Date:  2015-09-25       Impact factor: 4.929

10.  Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.

Authors:  Dan Su; Lorraine J Gudas
Journal:  Biochem Pharmacol       Date:  2007-11-22       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.